Work

Effect of itraconazole or rifampicin on the pharmacokinetics (PK) of osimertinib (AZD9291).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e14100

Authors: Karthick Vishwanathan, James Chih-Hsin Yang, Jong-Seok Lee, Matthew Krebs, Paul A. Dickinson, Khanh Bui, Doris Weilert, Karen So, Karen Thomas, R Donald Harvey

Institutions: AstraZeneca (United States), National Taiwan University Hospital, Seoul National University, Seoul National University Bundang Hospital, The Christie NHS Foundation Trust, IQVIA (United States), AstraZeneca (United Kingdom), Winship Cancer Institute

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2808020760

Cites:

Cited by: 3

Related to: 10